Lipid-based Nanocarriers for Enhancing Brain-targeted Delivery of Quer

Introduction

Major depressive disorder (MDD) represents a globally significant public health concern, affecting over 300 million individuals worldwide and exacerbating the global disease burden.¹ Traditional antidepressants targeting the…